Bioasis Technologies is a biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases. It develops an xB3 platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of CNS disorders, including brain cancers and neurodegenerative diseases.